RNU6-826P

Across TCGA pan-cancer cohorts, RNU6-826P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-826P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-826P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-826P expression acts as an unfavorable survival marker.

KIRC, KICH, and LUAD are the cancer types where RNU6-826P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.510	0.657	<.001	102	view →
KICH	OS	Tertile	All	0.254	0.905	<.001	102	view →
LUAD	DFS	Tertile	III,IV	0.378	0.726	<.001	99	view →
THCA	OS	Tertile	II,III,IV	0.173	0.903	<.001	75	view →
ACC	OS	Tertile	All	0.410	0.817	<.001	72	view →
LIHC	DFS	Tertile	All	0.374	0.567	<.001	60	view →
BRCA	OS	Tertile	III,IV	0.103	0.550	<.001	30	view →
PAAD	DFS	Tertile	II,III,IV	0.252	0.449	.025	27	view →
BLCA	DFS	Tertile	All	0.209	0.526	.003	27	view →
DLBC	DFS	Quartile	II,III,IV	0.396	0.853	.033	12	view →
KIRP	OS	Tertile	All	0.284	0.731	.015	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-826P–KIRC (OS)

Open the KIRC breakdown →